The BioCentury 100, NYSE Arca Biotechnology (BTK) and NASDAQ Biotechnology (NBI) were not in lockstep in 1Q due to differences in the indices' makeup. The BC100 and BTK rose 10% and 11%, respectively, last quarter, while the